市場調査レポート

商品コード

1569472

肺炎検査の市場規模、シェア、成長分析：製品タイプ別、タイプ別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Pneumonia Testing Market Size, Share, Growth Analysis, By Product Type, By Type, By End-user, By Region - Industry Forecast 2024-2031

出版日: 2024年10月13日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

肺炎検査の世界市場規模は、2022年に5億2,500万米ドルと評価され、2023年の5億5,965万米ドルから2031年には9億3,320万米ドルに達し、予測期間（2024-2031年）のCAGRで6.60％の成長が予測されています。

肺炎検査市場は、その成長軌道を形成する様々なダイナミックな促進要因と制約要因の影響を受けています。特に高齢化社会と慢性疾患患者における肺炎罹患率の増加は、大気汚染レベルの上昇と並んで、効果的な診断ソリューションの需要を大きく促進しています。これと並行して、特に小児や高齢者といったリスクの高い集団における早期診断と治療の必要性に対する意識の高まりが、市場をさらに牽引しています。分子診断やポイントオブケア検査を含む診断法の技術的進歩は、特に十分なサービスを受けていない地域における検査精度とアクセシビリティを高める上で極めて重要です。しかし、地域によっては経済的な制約から先進的な診断薬へのアクセスが制限されるなどの課題があり、また厳しい規制当局の承認が製品のイノベーションと市場参入を阻害する可能性もあります。こうしたハードルにもかかわらず、予防ヘルスケアへの注目の高まりと、手頃な価格と精度を向上させるための継続的な研究により、当面は市場の勢いが持続すると予想されます。同様に、バイオマス発電分野も、気候変動が懸念される中、よりクリーンなエネルギー源の必要性に後押しされ、大きな成長を遂げています。有機物を原料とするバイオマスは、輸入への依存を減らしつつエネルギー安全保障を促進する、持続可能なエネルギーソリューションを提示しています。再生可能エネルギーへの取り組みを支援する政府の政策も、バイオマスプロジェクトへの投資を世界的に後押ししています。とはいえ、市場は、他産業とのバイオマス原料の競合、環境への悪影響の可能性、物流のハードル、エネルギー変換プロセスの技術的限界などの課題に直面しています。世界のエネルギー情勢においてバイオマスの可能性を最大限に引き出すには、こうした課題に対処することが極めて重要です。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Thermo Fisher Scientific Inc.（US）
Quidel Corporation（US）
Becton, Dickinson, and Company（US）
Meridian Bioscience, Inc.（US）
Qiagen N.V.（Netherlands）
bioMerieux SA（France）
Bio-Rad Laboratories Inc.（US）
Cardinal Health Inc.（US）
Hologic Inc.（US）
La Roche Ltd.（Switzerland）
Abbott Laboratories（US）
Quest Diagnostics（US）
Luminex Corporation（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Agena Bioscience, Inc.（US）
Roche Diagnostics（Switzerland）
Grifols, S.A.（Spain）
PerkinElmer, Inc.（US）
Genoa Healthcare, LLC（US）
SeraCare Life Sciences, Inc.（US）
Randox Laboratories Ltd.（UK）
Acon Laboratories, Inc.（US）

Product Code: SQMIG35D2250

Global Pneumonia Testing Market size was valued at USD 525 million in 2022 and is poised to grow from USD 559.65 million in 2023 to USD 933.2 million by 2031, growing at a CAGR of 6.60% during the forecast period (2024-2031).

The pneumonia testing market is influenced by various dynamic drivers and constraints that shape its growth trajectory. Increasing pneumonia prevalence, particularly among aging populations and those with chronic diseases, alongside rising air pollution levels, significantly propels demand for effective diagnostic solutions. Alongside this, heightened awareness of the need for early diagnosis and treatment in at-risk groups, particularly children and the elderly, further drives the market. Technological advancements in diagnostic methods-including molecular diagnostics and point-of-care testing-are crucial in enhancing testing accuracy and accessibility, particularly in underserved areas. However, challenges such as economic limitations in certain regions restrict access to advanced diagnostics, while stringent regulatory approvals can impede product innovation and market entry. Despite these hurdles, a growing focus on preventive healthcare and ongoing research to improve affordability and accuracy is expected to sustain market momentum in the foreseeable future. Similarly, the biomass power generation sector is experiencing significant growth, fueled by the need for cleaner energy sources amid climate change concerns. Biomass, sourced from organic materials, presents a sustainable energy solution that promotes energy security while reducing reliance on imports. Government policies supporting renewable energy initiatives also bolster investment in biomass projects globally. Nevertheless, the market faces challenges, including competition for biomass feedstock with other industries, the potential for negative environmental impacts, logistical hurdles, and technological limitations in energy conversion processes. Addressing these challenges will be crucial for unlocking the full potential of biomass in the global energy landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pneumonia testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global pneumonia testing Market Segmental Analysis

Global Pneumonia Testing Market is segmented by Product Type, Type, End-user, and region. Based on Product Type, the market is segmented into Instruments, Reagents & Consumables. Based on Type, the market is segmented into Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, Others. Based on End-user, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global pneumonia testing Market

Demographic trends represent a significant market driver for the global pneumonia testing market, as aging populations worldwide are witnessing a rise in the incidence of pneumonia. With increased life expectancy, many elderly individuals face health challenges, including compromised immune systems that heighten their vulnerability to respiratory infections like pneumonia. This demographic shift not only amplifies the need for accurate and timely testing but also drives the demand for innovative diagnostic solutions tailored to this age group. Consequently, healthcare providers are increasingly focusing on enhancing pneumonia diagnostic capabilities, establishing a robust market for pneumonia testing technologies and services.

Restraints in the global pneumonia testing Market

One of the key market restraints for the global pneumonia testing market is the economic constraints experienced by healthcare systems, particularly in low- and middle-income regions. Limited healthcare budgets often hinder the ability of institutions to invest in advanced diagnostic technologies, which are essential for effective pneumonia testing. Disparities in healthcare access further exacerbate the issue, as marginalized communities may lack the necessary facilities and resources to implement comprehensive testing programs. These economic challenges lead to a slower adoption of pneumonia testing solutions, ultimately stalling market growth and limiting the availability of early diagnosis and treatment for this serious illness.

Market Trends of the global pneumonia testing Market

The global pneumonia testing market is experiencing a significant shift towards point-of-care testing, largely fueled by the demand for rapid diagnostics in emergency and primary care environments. With an increasing emphasis on early disease detection and prompt treatment initiation, point-of-care tests provide healthcare professionals with the capability to deliver immediate results, enhancing clinical decision-making and ultimately improving patient outcomes. This trend is further supported by technological advancements in diagnostic tools and an expanding focus on personalized healthcare solutions, thereby reshaping the landscape of pneumonia management and positioning point-of-care testing as a pivotal component of contemporary healthcare strategies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition
PESTEL Analysis

Pneumonia Testing Market by Product Type

Market Overview
Instruments
Reagents & Consumables

Pneumonia Testing Market by Type

Market Overview
Streptococcus-based
Legionella-based
Chlamydophila-based
Viral Pneumonia-based
Mycoplasma Pneumonia-based
Others

Pneumonia Testing Market by End-user

Market Overview
Hospitals & Clinics
Diagnostic Centers
Others

Pneumonia Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agena Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genoa Healthcare, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SeraCare Life Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acon Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

肺炎検査の市場規模、シェア、成長分析：製品タイプ別、タイプ別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Pneumonia Testing Market Size, Share, Growth Analysis, By Product Type, By Type, By End-user, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

肺炎検査市場：製品タイプ別

肺炎検査市場：タイプ別

肺炎検査市場：エンドユーザー別

肺炎検査市場規模：地域別